---
title: "KMT2C inactivation leads to PTEN downregulation and tolerance to DNA damage during cell cycle progression"
collection: publications
category: manuscripts
permalink: /publication/2025-10-28-kmt2c-pten
date: 2025-10-28
venue: "NPJ Precision Oncology"
authors: "Rampias T, Goutas A, Karagiannis D, Kanaki Z, Makri A, Hoxhallari L, Koukouzeli FE, Paraskevopoulou V, Tsouraki D, Paschalidis N, Avgeris M, Scorilas A, Klinakis A"
paperurl: "https://pubmed.ncbi.nlm.nih.gov/41152370/"

citation: "Pilala KM, Koroneou S, Papadimitriou MA, Panoutsopoulou K, Soureas K, Giagkos GC, Levis P, Linardoutsos D, Stravodimos K, <strong>Avgeris M</strong>, Scorilas A. <em>Loss of METTL3 m6A methyltransferase results in short-term progression and poor treatment outcome of bladder cancer patients.</em> <strong>Int J Cancer</strong>. 2026;158(3):763â€“774. doi: 10.1002/ijc.70147."
---

**PubMed:** [41152370](https://pubmed.ncbi.nlm.nih.gov/41152370/)  
**DOI:** [10.1038/s41698-025-01101-6](https://doi.org/10.1038/s41698-025-01101-6)
